Cleopatra Hospital Company · EGX:CLHO
Cleopatra Hospital — Cleopatra Hospitals Group — H1 2025 Earnings Presentation
62 slides from Cleopatra Hospital's earnings presentation, 2025
Slide 1: Transforming Healthcare in Egypt
Transforming Healthcare in Egypt Investor Presentation H1 2025
Slide 2: Disclaimer
Disclaimer This presentation contains forward-looking statements, including, but not limited to, statements concerning expectations, projections, objectives, targets, goals, strategies, future events, future revenues or performance, capital expenditures, financing needs, plans or intentions relating
Slide 3: Contents
CONTENTS 1 Cleopatra Hospitals Group Highlights 2 Macro Environment 3 Competitive Advantages 4 Growth Strategy & New Business 5 Governance & Management Information 6 H1 2025 in Review 7 Appendix
Slide 4: Cleopatra Hospitals Group Highlights
Cleopatra Hospitals Group Highlights 4
Slide 5: Our Mission, Vision and Values
Our Mission, Vision and Values ➢ A Patient-First Approach to Healthcare Our Mission • Delivering Leading Quality Services • Ensuring Safety of all Stakeholders • Growing Beds Supply & Expanding their Distribution • Improving Quality of Lives Everyday ➢ Sustainable Growth & Cross-Asset Collaboration
Slide 6: Cleopatra Hospitals Group Reports Exceptional Results for H1 2025
Cleopatra Hospitals Group Reports Exceptional Results for H1 2025 CHG delivered a strong top-line H1 2025 Snapshot performance in 1H 2025, supported by double-digit growth in patient volumes and greater case complexity. Half-year revenues totaled EGP 3,382 mn EGP 3,382 mn EGP 1,309 mn Consolidated r
Slide 7: Broad Network Across Greater Cairo
CHG enjoys a Broad Network spread Across Greater Cairo, penetrating underserved regions Leveraging a growing footprint, CHG continues to penetrate new segments of the population and provide high quality care to underserved regions across Greater Cairo Leveraging a growing footprint, CHG continues to
Slide 8: Fast Growing, Diversified Healthcare Services Provider
The Group is a Fast Growing, Diversified Healthcare Services Provider Group Revenue, EBITDA and Margins | EGP mn Revenue CAGR: 25% 5,420 3,382 31.7% 3,595 28.2% 2,372 29.1% 2,549 2,614 27.1% 26.5% 1,529 29.9% 26.1% 1,073 1,798 27.9% 1,990 27.1% 1,585 763 709 954 690 502 540 414 2019 2020 2021 2022
Slide 9: Macro Environment
Macro Environment 9
Slide 10: Growing Population & Prevalence of Lifestyle Diseases
Growing Population & Prevalence of Lifestyle Diseases Demographics Common Illnesses Breast Cancer Cases Communicable Diseases Lung Cancer Cases CAGR 3% 382,642 Cases CAGR 3% Acute Respiratory illness 33,863 Cases Chicken Pox 7,521 Cases 23,081 40,544 11,945 Brucella 6,045 2018 2040 2018 2040 • The m
Slide 11: Egypt's Healthcare Market Structure
Egypt’s Healthcare Market Structure Hospitals by Governorate and Geographical Disparities Medical Services in the Region EGYPT GCC MENA • Healthcare facilities are highly • Doctor/1,000 population ratio for concentrated in Cairo, Alexandria, Egypt is higher than both MENA Daqahleya & Giza which toge
Slide 12: Healthcare Investments in Egypt
Healthcare Investments in Egypt Private Sector as a % of total Healthcare Expenditure (2023) Government Spending 62% Government Healthcare Expenditure % of Total Expenditure 56% 58% 6.8% 4.7% 4.8% 5.2% 40% 39% 34% 36% 23% 21% 2018 2019 2020 2021 15% • Egypt’s House of Representatives approved budget
Slide 13: Competitive Advantages
P 7, -e . ae >» _ Benpstve 4 lam end = vantages
Slide 14: A leading healthcare services platform with sustainable competitive advantages
A leading healthcare services platform with sustainable competitive advantages CHG was a pioneering force in Egypt's private healthcare sector, recognizing its potential early on. The Group introduced an innovative 360-degree integrated management system, focused on delivering quality patient care a
Slide 15: Key Pillars of CHG's Centers of Excellence
A High-Level Perspective on the Key Pillars That Make Up CHG’s Definition of Centers of Excellence Defining Centers of Excellence Select Examples of CHG’s Centers of Excellence Competitive Defined Scope & Nursing & Residents Advantage & Sales Focus Team Differentiation Consumables Medical Equipment
Slide 16: Growth Strategy & New Business
Growth Strategy & New Business 16
Slide 17: Defined Core Growth Strategy
Defined Core Growth Strategy Integrating the platform to Leveraging payor and achieve higher efficiencies supplier relationships Geographic expansion in Egypt Enhancing utilization and linked to following optimizing existing capacity Establish centers of while expanding capacities and the main payor
Slide 18: Cleopatra October Hospital – CHG's Flagship Hospital of West Cairo
Cleopatra October Hospital – CHG’s Flagship Hospital of West Cairo & the Latest Addition Facility Overview Cleopatra October Current Facility + Extension Building • Transformed by CHG into a world-class tertiary hospital specialized in orthopedics, spine, rehabilitation & sports injuries (largest CO
Slide 19: Network Expansion through Sky Hospital – East Cairo
CHG continues its network expansion into underserved regions through Sky Hospital – East Cairo’s new State-of-the-Art Flagship project • In line with CHG’s strategy to expand into underserved regions, the Group is launching a top-tier hospital in East Cairo that will introduce c.240 new beds to the
Slide 20: Governance & Management Information
Governance & Management Information 20
Slide 21: Best-in-class corporate governance standards
CHG employs best-in-class corporate governance standards that are in line with the highest international standards… OPERATIONS ABC No Referral Fees Medical Council • CHG has a zero-tolerance approach to bribery and • CHG does not pay any referral fees or kickbacks to • CHG recently launched a group-
Slide 22: Board of directors dominated by independent and non-executive directors
… supported by a board of directors dominated by experienced independent and non-executive directors and focused on growing shareholder value… The Group’s Board of Directors provide the necessary oversight and combination of expertise to thoroughly oversee the Group’s corporate governance framework,
Slide 23: Highly competent and ambitious management team
… and led by a highly competent and ambitious management team comprised of accomplished industry veterans with vast experience in the healthcare sector The Group is managed by a seasoned team that brings along deep industry experience to their respective positions gained in leading regional and mult
Slide 24: H1 2025 in Review
H1 2025 in Review 24
Slide 25: Our Strategy drives consistent long-term value
Our Strategy drives consistent long-term value Cases Outpatient Inpatients Surgeries Revenues Served Visits 3 Year CAGR: 3 Year CAGR: 3 Year CAGR: 3 Year CAGR: 3 Year CAGR: 10.7% 10.3% 14.0% 8.1% 28.6% H1 2025: H1 2025: H1 2025: H1 2025: H1 2025: 692,576 34,485 565,695 20,076 EGP 3,382mn Y-o-Y Growt
Slide 26: H1 2025 Financial Performance Overview
H1 2025 Financial Performance Overview H1 2025 Snapshot ▪ During 1H2025, the Group delivered consolidated revenues of EGP 3,382mn, up from EGP 2,372mn in 1H2024. This strong performance was underpinned by higher volumes across all core services, supported by optimized patient case mixes and targeted
Slide 27: Efficiency Strategies Lead to Optimized Profitability
Efficiency Strategies Lead to Optimized Profitability ▪ In terms of COGS, most cost components demonstrated notable improvement, reflecting the Key COGS Cost Components to Revenue Ratios Group’s ability to optimize its case mix. Doctor fees saw a 2% improvement in the Doctor Fees-to- 23% Revenue rat
Slide 28: Group Revenue Contribution by Hospital
Group Revenue Contribution by Hospital Revenue Contribution by Hospital – 1H24 1% Cleopatra Hospital (CHC) 3% ▪ Largest revenue contributor in 1H2025 (32% of Group revenues, EGP 1,109mn, +33% y-o-y) 4% 2% 4% ▪ Broad-based growth across segments; inpatient revenues up 41% on +14% volumes ▪ Growth sup
Slide 29: Group Revenue Contribution by Segment
Group Revenue Contribution by Segment Revenue Contribution by Segment – 1H24 Inpatient Services 12% ▪ Contributed 23% of revenues in 1H2025 & 22% in 2Q2025 20% ▪ Revenues +51% y-o-y in 1H2025 (+53% in 2Q2025) 3% 6% ▪ Driven by +15% volumes (1H) / +22% volumes (2Q) ▪ ARP growth +32% (1H) / +26% (2Q)
Slide 30: Core Business Driven Growth
Core Business Driven Growth Volume, ARP, & Revenue | Volume, ARP, & Revenue | Volume, ARP, & Revenue | Surgeries Outpatients Laboratory EGP 24,481 Rev. in EGP Mn. Vol. In 000’ Rev. in EGP Mn. Vol. In 000’ Rev. in EGP Mn. EGP 30,173 25,0 00 700 600 EGP 457 EGP 525 350 1,20 0 EGP 245 EGP 326 400 350 6
Slide 31: Balance Sheet Highlights
Balance Sheet Highlights CAPEX Profile and Cash Flow Highlights ▪ The Group maintained its focus on network expansion and upgrades, with CAPEX outlays reaching c. EGP 1.3bn in 1H2025. ▪ Around 96% of spending related to assets for projects currently under construction. ▪ The largest share was alloca
Slide 32: CLHO.CA Share Performance
CLHO.CA Share Performance CHG’s Price Performance | Rebased to 100 Valuation Multiples 1 Month VWAP Closing Aug 28th 14 8.23 8.76 12.4x 10.8x 8.9x 8.0x 12 7.6x 7.7x EV/EBITDA Valuation 10 Multiples (x) Volume (mn) 8 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 Q2 2025 6 4 29.8x 23.8x P/E 17.7x 2 14.0x 12
Slide 33: Appendix: Financial Statements
Appendix: Financial Statements 33
Slide 34: Consolidated Income Statement
Consolidated Income Statement Income Statement | EGP mn 2Q2024 2Q2025 % Change 1H2024 1H2025 % Change Revenues 1,191.2 1,763.5 48.0% 2,372.4 3,382.1 42.6% Cost of sales (763.0) (1,068.4) 40.0% (1,508.5) (2,072.8) 37.4% Gross profit 428.2 695.1 62.3% 863.8 1,309.4 51.6% Gross Profit Margin 36% 39% 36
Slide 35: Consolidated Balance Sheet
Consolidated Balance Sheet Balance Sheet | EGP mn 31 December 2024 30 June 2025 Non-current assets Fixed assets 4,642.2 5,795.4 Intangible assets 405.2 404.2 Right of use 75.6 430.7 Payment under investment - - Investment in associates 8.5 8.5 Total non-current assets 5,131.6 6,638.9 Current assets
Slide 36: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Cash Flow Statement | EGP 30 June 2024 30 June 2025 Cash flow from operating activities: Profit before tax 481.4 704.3 Adjustments for: Depreciation 87.3 108.8 Amortization of intangible assets 1.0 3.0 Allowance for impairment of current assets 17.7 42.4 Provision (2
Slide 37: Appendix: Photo Library
Appendix: Photo Library 37
Slide 38: Cleopatra Hospital
CHG Cleopatra Hospital 38
Slide 39: Cairo Specialized Hospital
Cairo Specialized Hospital 39
Slide 40: Nile Badrawi Hospital
®| Nile Badrawi Hospital 40
Slide 41: Al Shorouk Hospital
®| Al Shorouk Hospital 41 @ee
Slide 42: Cleopatra October Hospital
Cleopatra October Hospital 42
Slide 43: Cleopatra El Tagamoa Hospital
Cleopatra El Tagamoa Hospital 43
Slide 44: El Katib Hospital
®| El Katib Hospital a a. | A a 7
Slide 45: Bedaya Hospital
Bedaya Hospital 45
Slide 46: Cleopatra Clinics (East Cairo)
Cleopatra Clinics (East Cairo) 46
Slide 47: Cleopatra Clinics (West Cairo)
Cleopatra Clinics (West Cairo) 47
Slide 48: Cleopatra Clinics (Maadi)
Cleopatra Clinics (Maadi) 48
Slide 49: Cleopatra Clinics (Suez Governorate)
Cleopatra Clinics (Suez Governorate) 49
Slide 50: Cleopatra Clinics (Pyramids Clinic)
Cleopatra Clinics (Pyramids Clinic) 50
Slide 51: Cleo Alfa Cure – Oncology Center of Excellence
Cleo Alfa Cure – Oncology Center of Excellence 51
Slide 52: Cairo Specialized Hospital – Bone Marrow Transplantation Unit
Cairo Specialized Hospital – Bone Marrow Transplantation Unit 52
Slide 53: Cleopatra October Hospital – Aqua Therapy
Cleopatra October Hospital – Aqua Therapy 53
Slide 54: CleoDent – Dental Center of Excellence
CleoDent – Dental Center of Excellence 54
Slide 55: CleoSphinx – Nephrology Center of Excellence
CleoSphinx – Nephrology Center of Excellence 55
Slide 56: Nile Badrawi Hospital – Radiotherapy Center of Excellence
Nile Badrawi Hospital – Radiotherapy Center of Excellence 56
Slide 57: Al Shorouk Hospital – RoboSurgery Center of Excellence
Al Shorouk Hospital – RoboSurgery Center of Excellence 57
Slide 58: Al Shorouk Hospital – Newly Renovated Inpatient Ward
Al Shorouk Hospital – Newly Renovated Inpatient Ward 58
Slide 59: Cleopatra Hospital – Outpatient Clinics
Cleopatra Hospital – Outpatient Clinics 59
Slide 60: Cairo Specialized Hospital – Emergency Department
Cairo Specialized Hospital – Emergency Department 60
Slide 61: Al Shorouk Clinics
[@] Al Shorouk Clinics @e 61
Slide 62: Thank you
Thank you INVESTOR RELATIONS CONTACTS SHAREHOLDER INFORMATION ir@cleohc.com Email: ir@cleohc.com https://www.cleopatrahospitals.com/en/investors/ EGX: CLHO.CA Website: https://www.cleopatrahospitals.com/en/investors/ Listed: June 2016 Shares Outstanding: 1.4 billion 62
Cleopatra Hospitals Group — H1 2025 Earnings Presentation on 6ix